RSS   Newsletter   Contact   Advertise with us
Post Online Media

Reata Pharmaceuticals appoints vice president

Reata PharmaceuticalsReata Pharmaceuticals, a company focused on lung diseases, announced the appointment of David Chapman as vice president, marketing.

Mr. Chapman joins the company with over 25 years of biopharmaceutical sales, marketing, and market access experience.

Over the past decade, Mr. Chapman served in leadership roles at Relypsa, Boehringer Ingelheim, and Pfizer.

During his tenure at Boehringer Ingelheim, Mr. Chapman served as the Global Marketing lead for an interferon-free asset for hepatitis C and led Global Market Access activities across a broad range of therapeutic areas.

Most recently, he served as the Director of Managed Markets at Relypsa where he led a team of National and Regional Account Managers that gained new or improved access for Veltassa.

Mr. Chapman received a B.S. in Management from Auburn University, Auburn, AL.


 LATEST MOVES FROM Texas 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy